SKSeungbeom Ko

Seungbeom Ko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Seungbeom Ko has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mature microRNA-binding protein QKI suppresses extracellular microRNA let-7b release

    by Kyung-Won Min, Kyoung-Min Choi, Hyejin Mun, Seungbeom Ko, Ji Won Lee, Cari A. Sagum, Mark T. Bedford, Joe R. Delaney, Jung-Hyun Cho, Ted M. Dawson, et al.

    Argonaute (AGO), a component of RNA-induced silencing complexes (RISCs), is a representative RNA-binding protein (RBP) known to bind with mature microRNAs (miRNAs) and is directly involved in post-transcriptional gene silencing. However, despite the biological significance of miRNAs, the roles of other miRNA-binding proteins (miRBPs) remain unclear in the regulation of miRNA loading, dissociation from RISCs and extracellular release. In this study, we performed protein arrays to profile miRBPs and identify 118 RBPs that directly bind to miRNAs. Among those proteins, the RBP quaking (QKI) inhibits extracellular release of the mature microRNA let-7b by controlling the loading of let-7b into extracellular vesicles via additional miRBPs such as AUF1 (also known as hnRNPD) and hnRNPK. The enhanced extracellular release of let-7b after QKI depletion activates Toll-like receptor 7 (TLR7) and promotes the production of proinflammatory cytokines in recipient cells, leading to brain inflammation in the mouse cortex. Thus, this study reveals the contribution of QKI to the inhibition of brain inflammation via regulation of extracellular let-7b release.


  • Blood-declustering excretable metal clusters assembled in DNA matrix

    by Jaiwoo Lee, Quoc-Viet Le, Seungbeom Ko, Sungtaek Kang, Robert B. Macgregor, Gayong Shim, Yu-Kyoung Oh


  • Open Access

    Profiling of RNA-binding Proteins Interacting With Glucagon and Adipokinetic Hormone mRNAs

    by Seungbeom Ko, Eunbyul Yeom, Yoo Lim Chun, Hyejin Mun, Marina Howard-McGuire, Nathan T. Millison, Junyang Jung, Kwang-Pyo Lee, Changhan Lee, Kyu-Sun Lee, et al.

    Ko S, et al. J Lipid Atheroscler. 2022 Jan;11(1):55-72. https://doi.org/10.12997/jla.2022.11.1.55


  • Chemokine-mimetic plerixafor derivative for tumor-specific delivery of nanomaterials

    by Seungbeom Ko, Gayong Shim, Jinyoung Kim, Yu-Kyoung Oh

    Here, we report that chemokine-mimetic plerixafor derivatives could govern tumor-specific delivery and functional effects of nanomaterials. Reduced graphene oxide (rGO) nanosheets were used as a model functional nanomaterial, and plerixafor-conjugated lipid (PL/rGO) or a benzylcyclam derivative of plerixafor-conjugated lipid (BPL/rGO) was physically adsorbed onto the surface of rGO. The cellular uptake of surface-modified rGO was dependent on overexpression of the CXCR4 chemokine receptor on cancer cells. In KB cells, the binding affinity of BPL/rGO for CXCR4 was 6.8-fold greater than that of PL/rGO. Notably, cellular uptake patterns correlated with in vitro photothermal anticancer efficacy. The tumor distribution of BPL/rGO was higher than that of PL/rGO and plain rGO in mice bearing CXCR4-overexpressing tumors, whereas the distribution of the various rGO forms was similar in mice harboring CXCR4-negative tumors. Moreover, complete photothermal tumor ablation was observed in BPL/rGO-treated mice bearing CXCR4-positive KB cell tumors, but not in CXCR4-negative MCF-7 cell tumors. These results provide evidence that BPL can be used to enhance the delivery of nanomaterials to CXCR4-overexpressing tumors. Chemokine-mimetic BPL can be further applied for nanomaterial-based delivery of photosensitizers, anticancer drugs, or diagnostic tumor imaging agents in CXCR4-overexpressing cancer patients.